New ASMI Board
November 11, 2015
The Australian Self-Medication
Industry this morning announced
its new board of directors, following
the organisation’s annual general
meeting which took place today.
Members include Rob Barnes
of Aspen PharmaCare, Shayne
Byrne from Perrigo, Lindsay Forrest
of Lindsay Forrest Consultant,
Takeda’s James Jones, Phil Lynch
of Johnson & Johnson Pacific,
Ego Pharmaceuticals ceo Alan
Oppenheim, Elizabeth Reynolds
from GlaxoSmithKline Consumer
Healthcare, Paul Rose of Pfizer and
Mark Sargent of Bayer Australia.
Mark Sargent is the interim
chairman until the first board
meeting at which office bearers will
be formally elected.
The ASMI annual conference,
titled “Innovating to a Self Care
Future” is also taking place today in
Sydney.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Nov 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Nov 15
